I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Leflunomide is equally efficacious and safe compared to low..:
Harindu Wijesinghe
;
Priyadharshini Galappatthy
;
Rajiva de Silva
...
http://link.springer.com/article/10.1186/s12891-017-1673-3. , 2017
Link:
https://doi.org/10.1186/s12891-017-1673-3
RT Journal T1
Leflunomide is equally efficacious and safe compared to low dose rituximab in refractory rheumatoid arthritis given in combination with methotrexate: results from a randomized double blind controlled clinical trial
UL https://suche.suub.uni-bremen.de/peid=base-ftdoajarticles:oai:doaj.org_article:2617a84d50bf4768a96be4011047f123&Exemplar=1&LAN=DE A1 Harindu Wijesinghe A1 Priyadharshini Galappatthy A1 Rajiva de Silva A1 Suranjith L. Seneviratne A1 Ushagowry Saravanamuttu A1 Preethi Udagama A1 Melanie Hart A1 Peter Kelleher A1 Upul Senerath A1 Rohini Fernandopulle A1 Lilani P. Weerasekera A1 Lalith S. Wijayaratne PB BMC YR 2017 K1 Rheumatoid arthritis K1 Rituximab K1 Leflunomide K1 Clinical trial K1 Biologic Disease Modifying Anti Rheumatic Drugs (DMARDS) K1 Diseases of the musculoskeletal system K1 RC925-935 JF http://link.springer.com/article/10.1186/s12891-017-1673-3 LK http://dx.doi.org/https://doi.org/10.1186/s12891-017-1673-3 DO https://doi.org/10.1186/s12891-017-1673-3 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)